Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
—1,101.371,103.631,105.311,091.41——
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
—613.35613.35613.35601.49——
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
—1,198.831,199.681,199.751,182.41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
—1,755.951,754.061,756.031,734.69——
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
—638.51637.41637.41633.05——
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
—843.52843.35846.40837.93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
—215.95215.95216.84215.06——
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
—3,138.913,189.303,230.853,174.76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
—934.37934.72938.26927.50——
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
—1,477.431,474.121,474.121,451.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
—2,380.192,389.342,403.042,380.47——
6IB:FRA
Innovent Biologics Inc
€9.26
+3.62%
(+0.32) 1D
Apr 24, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 6IB...
Open
€9.19
High
€9.26
Low
€9.19
Mkt. cap
148.88B
Avg. vol.
221.00
Volume
0.00
52-wk high
€11.70
52-wk low
€5.55
No. of employees
8K
News stories
From sources across the web
Profile
Innovent Biologics, Inc. is a publicly listed Chinese biopharmaceutical company that is headquartered in Suzhou, Jiangsu. Wikipedia
About Innovent Biologics Inc
CEOMichael Yu
Employees7.5K
FoundedNov 28, 2011
Headquarters-
SectorBiotechnology
Websiteinnoventbio.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
2.98B
2.98B
3.54B
3.54B
Cost of goods sold
676.78M
676.78M
860.88M
860.88M
Cost of revenue
676.78M
676.78M
860.88M
860.88M
Research and development expenses
504.40M
504.40M
807.71M
807.71M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.41B
1.41B
1.91B
1.91B
Operating expense
1.91B
1.91B
2.72B
2.72B
Total operating expenses
2.59B
2.59B
3.58B
3.58B
Operating income
386.78M
386.78M
-35.72M
-35.72M
Other non operating income
13.49M
13.49M
45.19M
45.19M
EBT including unusual items
448.56M
448.56M
-29.10M
-29.10M
EBT excluding unusual items
434.82M
434.82M
-17.35M
-17.35M
Income tax expense
31.40M
31.40M
-18.72M
-18.72M
Effective tax rate
7.00%
7.00%
64.33%
64.33%
Other operating expenses
-
-
-
-
Net income
417.16M
417.16M
-10.38M
-10.38M
Net profit margin
14.01%
14.01%
-0.29%
-0.29%
Earnings per share
-
-
-
-
Interest and investment income
95.19M
95.19M
124.16M
124.16M
Interest expense
-30.63M
-30.63M
-9.17M
-9.17M
Net interest expenses
64.55M
64.55M
114.99M
114.99M
Depreciation and amortization charges
-
-
-
-
EBITDA
514.79M
514.79M
92.29M
39.42M
Gain or loss from assets sale
355.50K
355.50K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer